This is a clean win for Medtronic — the case is closed with no settlement or ongoing liability. Monitor for any appeal notice (unlikely given the pleading-stage dismissal), but the ruling removes a discrete overhang on the SynchroMed II product line.
Price Chart
Executive Summary
The Northern District of Ohio granted Medtronic's motion to dismiss with prejudice all claims in a product-liability lawsuit over the SynchroMed II implantable drug pump. The court found the plaintiffs failed to plead specific facts linking the alleged pump malfunction to a manufacturing defect or a nonconformity with representations, and dismissed the derivative claims for loss of consortium and punitive damages. This final dismissal removes a discrete litigation risk for Medtronic.
Court Ruling Details
Key Facts
- Court granted Medtronic's motion to dismiss all counts (defective manufacturing, nonconformity with representation, loss of consortium, punitive damages) with prejudice.
- Plaintiffs alleged the SynchroMed II pump malfunctioned, causing opioid withdrawal, but failed to plead a specific manufacturing deviation or how the device failed to conform to representations.
- The court noted a nine-year gap between the cited FDA warning letters (2006-2013) and the 2022 implantation of the device at issue, making historical violations insufficient to infer a defect.
- Case closed — no damages awarded, no injunction issued, no ongoing exposure from this lawsuit.
Financial Impact
No damages awarded; the case was dismissed with prejudice. The opinion does not state any pleaded damages amount.
Risk Factors
- Plaintiffs could appeal to the Sixth Circuit, though the dismissal was on well-established pleading standards and the opinion is thorough.
- Other pending SynchroMed II cases (if any) are unaffected by this ruling — each case stands on its own facts.
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-c84989a6e2-MDT |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | 8-K | $94.63 | awaiting T+60 | — | $94.70 (+0.07%) |
Oct 16, 2026 9d ago | Insider Cluster | $92.77 | awaiting T+60 | — | $94.70 (−2.08%) |
Oct 16, 2026 9d ago | Insider Cluster | $92.77 | awaiting T+60 | — | $94.70 (−2.08%) |
Oct 15, 2026 11d ago | 144 | $95.45 | awaiting T+60 | — | $94.70 (−0.79%) |
Oct 14, 2026 12d ago | SC TO-I/A | $94.23 | awaiting T+60 | — | $94.70 (+0.50%) |
Oct 14, 2026 12d ago | 425 | $94.23 | awaiting T+60 | — | $94.70 (+0.50%) |
Oct 13, 2026 13d ago | SC TO-I/A | $93.01 | awaiting T+60 | — | $94.70 (+1.82%) |
Oct 13, 2026 13d ago | 425 | $93.01 | awaiting T+60 | — | $94.70 (+1.82%) |
Oct 9, 2026 16d ago | 425 | $91.93 | awaiting T+60 | — | $94.70 (+3.01%) |
Oct 8, 2026 17d ago | 425 | $88.48 | awaiting T+60 | — | $94.70 (+7.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers